Teligent Pharma, Inc. drugs

10 results
Teligent Pharma, Inc.
Usage: Clobetasol Propionate Lotion 0.05% is indicated for relieving inflammatory and pruritic symptoms of corticosteroid-responsive dermatoses in adults (18+ years). Treatment is limited to 2 weeks, with possible extension for localized psoriasis. It should not be used on the face, axillae, groin, or in certain skin conditions.
Teligent Pharma, Inc.
Usage: Diclofenac Sodium Topical Solution is indicated for treating the signs and symptoms of osteoarthritis in the knee(s).
Teligent Pharma, Inc.
Usage: Topical corticosteroids are used to relieve inflammation and itching associated with skin conditions responsive to corticosteroid treatment.
Teligent Pharma, Inc.
Usage: Fluocinonide Ointment, 0.05% is indicated for relieving inflammatory and itchy symptoms associated with corticosteroid-responsive dermatoses.
Teligent Pharma, Inc.
Usage: Fluocinonide Cream USP, 0.05% is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.
Teligent Pharma, Inc.
Usage: FORTAZ is indicated for treating infections caused by susceptible organisms, including lower respiratory tract infections, skin and skin-structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections, and central nervous system infections like meningitis.
Teligent Pharma, Inc.
Usage: Topical corticosteroids are used to relieve inflammation and itching associated with skin conditions responsive to corticosteroid treatment.
Teligent Pharma, Inc.
Usage: Topical corticosteroids are indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.
Teligent Pharma, Inc.
Usage: Topical corticosteroids are indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.

Zantac (ranitidine hydrochloride)

(ranitidine hydrochloride)
Teligent Pharma, Inc.
Usage: ZANTAC Injection is indicated for hospitalized patients with pathological hypersecretory conditions, intractable duodenal ulcers, or for short-term use in patients unable to take oral medication.